Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229622 | SCV000283551 | uncertain significance | Fanconi anemia | 2025-01-22 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 743 of the FANCA protein (p.Gly743Asp). This variant is present in population databases (rs763187355, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 237039). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt FANCA protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001276547 | SCV002786025 | uncertain significance | Fanconi anemia complementation group A | 2021-09-16 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001276547 | SCV001462945 | uncertain significance | Fanconi anemia complementation group A | 2020-05-01 | no assertion criteria provided | clinical testing |